SciSparc Total Assets 2017-2024 | SPRC

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

SciSparc total assets from 2017 to 2024. Total assets can be defined as the sum of all assets on a company's balance sheet.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

SciSparc total assets from 2017 to 2024. Total assets can be defined as the sum of all assets on a company's balance sheet.

Related Stocks
Company Name	Market Cap
Chugai Pharmaceutical (CHGCY)	$67.7B
Zoetis (ZTS)	$65.3B
Daiichi Sankyo, - (DSNKY)	$46.2B
Takeda Pharmaceutical (TAK)	$45.9B
BeOne Medicines - (ONC)	$31.6B
Sandoz Group AG (SDZNY)	$25.8B
Summit Therapeutics (SMMT)	$21.3B
Merck (MKKGY)	$16.4B
Shionogi (SGIOY)	$15.2B
United Therapeutics (UTHR)	$13.6B
Neurocrine Biosciences (NBIX)	$12.4B
Orion OYJ (ORINY)	$10.8B
IPSEN (IPSEY)	$10.4B
Madrigal Pharmaceuticals (MDGL)	$7.7B
Corcept Therapeutics (CORT)	$7.6B
Grifols, S.A (GRFS)	$7.3B
Stevanato Group S.p.A (STVN)	$7.2B
Ionis Pharmaceuticals (IONS)	$6.6B
Hikma Pharmaceuticals Plc (HKMPF)	$5.9B
Ono Pharmaceutical (OPHLF)	$5.1B
Soleno Therapeutics (SLNO)	$4.4B
Hypermarcas (HYPMY)	$2.9B
NewAmsterdam Pharma (NAMS)	$2.8B
AMNEAL PHARMACEUTICALS, INC (AMRX)	$2.7B
Crinetics Pharmaceuticals (CRNX)	$2.5B
Catalyst Pharmaceuticals (CPRX)	$2.4B
Centessa Pharmaceuticals (CNTA)	$2.3B
Ocular Therapeutix (OCUL)	$2.1B
Endo (NDOI)	$1.8B
BioCryst Pharmaceuticals (BCRX)	$1.7B